chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mother reported redness and swelling at injection site, was seen by PCM and given Benadryl.
HEADACHE; This spontaneous report received from a consumer concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache. This report was non-serious.
A spontaneous report has been received from health professional concerning about female patient. Patient relevant history, concurrent diseased and concomitant drugs were not provided. Patient had been receiving nasal FLUMIST QUADRIVALENT started on an unknown date. The patient was administered full dose of FLUMIST on same nostril. The outcome of the event of full dose of FLUMIST administered on same nostril was unknown. The report was considered to be non-serious by reporter.
sour arm; fatigue; fever; chill; shortness of breath; coughed; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 44-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: FF8839), via an unspecified route of administration, administered in Arm Left on 13Oct2021 at 12:00 (age at the time of vaccination was 44 years) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation at workplace clinic. The patient medical history was not reported. Concomitant medication(s) included influenza vaccine (FLU VACCINE VII) taken for an unspecified indication from 28Sep2021 to an unspecified stop date. Other vaccine 4 weeks included Flu shot. Historically the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 02Feb2021 (age at the time of vaccination was 44 years) as DOSE 2, SINGLE and received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 15Jan2021 (age at the time of vaccination was 44 years) as DOSE 1, SINGLE for both covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. On 13Oct2021 at 20:00, the patient experienced sour arm, fatigue, fever, chill, shortness of breath and coughed. It was reported that, in addition to the usual and most common reactions (sour arm, fatigue,) the patient started to develop a fever and chill later at night. The patient woke up with fever around 2:30 am and then started to experience shortness of breath and coughed. He took an Advil and the fever started to alleviate. Shortness of breath was also gone after about 1 to 2 hours. During the next day he still had chills and fever and tried to control them with Advil. No shortness of breath was experienced the next day. No prolonged hospitalization was reported. Therapeutic measures were taken as a result of fatigue, fever, chill, shortness of breath and coughed. On 13Oct2021, the patient underwent lab tests and procedures which included fever: unknown result. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient has not been diagnosed with COVID-19. The outcome of all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Robust reaction at site-flu like symptoms 2-28/3-07. Lesion in pubic area 3-07-03 to 3-14-03.
Pt presented on 03/20/2002 with 50 pieces of red, firm, swollen area at injection site (left arm SQ).
Extreme fatigue, muscle and joint pain, headache, nausea, pain at injection site, extreme chills. On 3/15/2019 ..I woke up with a rash all over the upper part of my arm.
About 2 weeks after second Coivd (Pfizer) vaccine, developed 24/7 Tinnitus
The pharmacist drew up the Moderna Pediatric dose instead of the Moderna Bivalent dose for the patient. No adverse reaction.
This spontaneous report was received from a other health professional refers to a patient of unknown age. On 09-SEP-2014 the patient was vaccinated with ROTATEQ Vial, lot # K001935; expiry: 08-DEC-2015 (dose, dose # and route unspecified). No concomitant medications were reported. On 09-SEP-2014, it was reported that the patient was exposed to temperature outside of the proper storage range. No adverse effect reported. The outcome of were exposed to temperature outside of the proper storage range and no adverse effect reported is unknown. There was no product quality complaint (PQC) involved. This is one of several reports received from the same source. Additional information has been requested.
hivers on lower back to side and left leg; joint stiffness over entire body; This is a spontaneous report from a contactable pharmacist. A 54-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; lot number: ett9899, expiration date: unknown), intramuscularly on the left arm on 17Dec2020 at 10:45 at a single dose for COVID-19 immunization administered at the hospital. Relevant medical history included hypertension, diabetes, tachycardia, diverticulitis, and known allergies to pimentos. Concomitant medications included metformin and metoprolol tartrate (LOPRESSOR). The patient previously took valaciclovir hydrochloride (VALTREX) and experienced allergies to it. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced hivers on lower back to side and left leg and joint stiffness over entire body on an unspecified date in Dec2020 with hive improvement several days later. The patient received diphenhydramine (BENADRYL) and paracetamol (TYLENOL) orally from the emergency room as treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events were assessed as non-serious. The patient recovered from the events "hivers on lower back to side and left leg and joint stiffness over entire body" on an unspecified date in Dec2020.
A spontaneous report has been received from a Health Professional concerning a patient, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient reported expired FLUMIST QUADRIVALENT administered. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious by the reporter. Summary of follow-up information received by AstraZeneca/MedImmune on 05-Feb-2014 from Health Professional: AZ received date in first version was changed. Reporter tab updated.
She is saying that her chest hurts, ants moving from all over chest; She is saying that her chest hurts, ants moving from all over chest; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), CHEST PAIN (non-serious), outcome "unknown" and all described as "She is saying that her chest hurts, ants moving from all over chest".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. Follow-up attempts completed. No further information is expected.
Called to where 16 yr old pt sat in observation area with her father. Pt was alert but pale. According to Pt father Pt lost consciousness for a second in chair. PT states she's afraid of needles but she did not faint from first dose of COVID-19 vaccine. PT states she felt lightheaded but did not mention any other symptom. PT  father states PT does not have any medical history.Pt states she only had a very small breakfast and no lunch.  Assisted PT lay on yoga mat with legs elevated. First set of vital signs were taken at 1:40: BP 109/74; P 72; Res 18; O2 Sat 100%. Second set of VS taken at 1:50 with BP 104/65, P67; Res 18 and O2 Sat 100%. PT  states she felt better; her skin color turned normal. Assisted PT  sitting up on the yoga mat for a few minutes then back to her chair. Water and snack provided to PT. However, around 2PM PT  felt lightheaded again while in chair, she lay herself down on the ground. At this time she felt  periodic nausea. Her VS at 2PM BP 108/64; P67;resp 18. Her skin color was normal. Cold towel was placed on forehead with some comfort. 7-UP given to relieve nausea. PT rested on the ground until 2:30 then went back to her chair.  Her symptom finally subsided and she left observation area with her father around 2:45PM.
Approx. 3 red papules 22mmm in size; 2 on back of neck. Fever 103 right before being seen. Dx- phamaus ? possible VARIVAX reaction.
pt c/o redness & soreness w/some itching to rt deltoid;denies any fever;pt is able to move arm well;instructed to take APAP or motrin & apply warm to cool compress;
pt recvd vax 26sept; pt presents w/ small maculopapular rash on face, trunk, arms, legs, buttocks; rash pink to dusky red w/ some merging of rash; rash resembled measles; no koplik spots; pt afebrile w/ sl runny nose; pmd states rxn to vax
Pfizer-BioNTech COVID-19 Vaccine EUA: During the post-observation period, vaccine recipient stated that she felt faint and decided to lay on the floor. She was helped to a wheelchair and brought to the EMS tent for observation in stretcher. She felt better and was able to walk out of the clinic.
Injection site soreness ~~ resolved with time Chills ~~ 8:30 pm (6/26) to 7 am (6/27) resolved with time Fever ~~ 100.1 (1am thru 7 am) 6/27 ~~ resolved with Tylenol and time
Body aches,; Fatigue; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 42-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included paroxetine (MANUFACTURER UNKNOWN) from unknown date, for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 08:00, the patient experienced body aches, fatigue and nausea. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body aches, fatigue and nausea was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After both the first and second doses of the SHINGRIX vaccine. First dose was May 17, 2018 and second dose was August 10, 2018. Received the first dose at pharmacy and the second at my doctor's office. I began to feel sick (tired, headache) 4-6 hours after both shots. Both times a shingles-like rash developed at the injection site. The first rash was about 3-5 inches in size and lasted 3-4 days. The second rash seems a little smaller. The day after the shots I felt worse (tired,headache, general malaise) than the day of the shot. Tylenol/Advil helped.
about 1/2hr p/vax devel severe pain in inj arm radiating to chest wall, also numbness of fingers, nausea, lightheadedness, pain involved entire arm, had very limited ROM;pt was treated w/Ibuprofen, chlorphenihamine & IV fluid;resolved 5hr
arm swollen; soreness at the injection site; red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swollen), INJECTION SITE PAIN (soreness at the injection site) and INJECTION SITE ERYTHEMA (red spot at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swollen), INJECTION SITE PAIN (soreness at the injection site) and INJECTION SITE ERYTHEMA (red spot at the injection site). At the time of the report, PERIPHERAL SWELLING (arm swollen), INJECTION SITE PAIN (soreness at the injection site) and INJECTION SITE ERYTHEMA (red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Patient felt anxious and felt that heart rate was irregular.  Patient has a history of afib.
developed shingles on left chest and back started 3/28/2021 and still suffering with today 4/8/2021. took 7 day course of antiviral medication and now on gabapentin and Tylenol for the nerve pain
Patient to ER for fever of 105.7. Work up done. Rocephin given. Blood culture came back positive.
No adverse symptoms; the patient was vaccinated with M-M-R II and VARIVAX on 07/24/2019 and PROQUAD on 9/4/2019; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 24-JUL-2019, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (lot number, expiration date, dose and route of administration were not provided) and the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot number, expiration date, dose and route of administration were not provided). On 04-SEP-2019, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection (lot number, expiration date, dose and route of administration were not provided) (inappropriate schedule of vaccine administered). No adverse symptoms were reported.
The night of vaccination 12/21 - burning thighs, hot to touch. 12/23 - felt fine most of the day. At around 2 PM, my left hand began to tingle which increased to full body tingling/pre syncope feeling. HR increased to 155. Went to the ER and was treated with fluids. Remained tachycardic around 100 with increasing HR when sitting up/walking.
Temperature max of 104 followed by febrile seizure/grandmal within 12 hours post immunization.  Parents had adm antipyretic with awareness of fever 6:30PM 12/30.  Called 911, went to er for observation, discharged to home around 4AM.
tested positive on her COVID test; tested positive on her COVID test; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer reported for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 18Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient got the first dose of the Pfizer COVID-19 Vaccine last March 18 and she just got back from a trip and she was tested positive on her COVID test. She was asking if that could be the vaccine being detected or something else. The patient underwent lab tests and procedures which included sars-cov-2 test: positive in Mar2021.  The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Status post vaccination , pt. experienced vasovagal syncope. Pt became dizzy, disoriented, and briefly unresponsive. Using a pulsometer, her HR was determined to be 49BPM with an O2sat of 99%. Patient was attended to and provided water, she became oriented and responsive within a few minutes.  The patient was monitored for 30 minutes.
Rash to (L) forehead just lateral to eye. Started 4 days after vaccine given. Due to location she was referred to ER for further evaluation by on call Ophthalmologist.
This report was reported by a nurse via sales rep and described the occurrence of faint in a 17-year-old female patient who received BEXSERO. On an unknown date, the patient experienced BEXSERO. On an unknown date, less than a day after receiving BEXSERO, the patient experienced faint and presyncope. On an unknown date, the outcome of the faint and presyncope were unknown. It was unknown if the reporter considered the faint and presyncope to be related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. The health care professional that patient received BEXSERO and became faint, almost passed out, and had to lay down. The patient recovered, left the office, and did not require any further medical intervention.
Tiredness; headache; muscle pain; chill; joint pain; fever; feeling unwell definitely; diarrhea; Sweating; really knocked me for a loop/knock me out; get sick; fever; feeling unwell; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EWO191), via an unspecified route of administration on an 04Jun2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient's historical vaccine includes first dose of BNT162b2 on unspecified date for COVID-19 immunisation and experienced no adverse effect. On Jun2021 the patient experienced get sick, tiredness, headache, muscle pain, chill, joint pain, fever, feeling unwell, diarrhoea, sweating and really knocked me for a loop/knock me out. It was reported that, did really well after the first injection but the second one is really knock me out. Reading about the side effects vaccine I received. I have quite of few of them here. I didn't think I would because the first injection I experience nothing. The second one really knocked me for a loop. I haven't been sick for two years and this really shot get sick from a vaccine. I don't think I ever been sick from a vaccine. but this one really turned me in. You have the side effects list here in and I can tell you which ones I have. You have all the side effect listed. I did not have the severe allergic reaction, of course so I needn't be at home but some of these the other one really is turning for look and it's been 2 days now. Tiredness, here is this one, the headache, the muscle pain, chill, joint pain, fever, feeling unwell definitely, and diarrhoea. That's what it got listed here and I had all of those. And I have all of those I just told you about. I am trying not to pass to anybody else because I don't want anybody else not get the second dose just because what I experience. I will stay silent, I mean, it's been rough last 2 days, still last two days. I guess, I am still not feeling well. I was experienced that they don't have listed as the side effect is sweat, Sweating and that could be a sign of having fever. The sweating It's just a bit just Pfizer knows that there is can reaction Pfizer sacks to the vaccine. May be not the anaphylactic shock somebody might get but I don't feel good. EWO191 would that be the lot number, and received it on June 4th, two days ago I am having this reaction to this. No nothing at all I just got to get better that's all, I hope it does not take too long. The outcome of the events was reported as recovering.  Information about lot/batch number has been requested.
None; reported as a medication error. Patient was inadvertently administered Moderna prior to the 18th birthday.
Narrative: COVID infection following COVID vaccine series and after previous COVID infection 2/12, Pfizer, dose #1 03/04, Pfizer, dose #2 01/10 COVID swab, result: detected 01/03 pt cc: runny nose, fever, sore throat, Nasal congestion, and cough exposure: unknown 01/03 pt admit ED cc: runny nose, fever, sore throat, Nasal congestion, and cough dx: Positive Covid LOS: 1 day 01/03 CXR impression: No acute cardiopulmonary disease. 01/10 pt admit ED cc/; symptoms are improving she has been without fever for 24 hours dx: COVID-19 retest LOS: 1 day 01/10 COVID swab, result: detected
Received FLUZONE Quadrivalent in (L) deltoid. C/O swollen lymph nodes and sore arm.
Patient started with rash, then was very fussy. This progressed into some sort of delopmental regression.  He was crawling before the vaccine, but stopped crawling and started tongue thrusting again.  These problems have slowly improved per parental report.
1/24/2022 - increased soreness/pain left-side, upper extremity and spread throughout the whole body. 1/24/2022 - lethargy. 1/25/2022 - fever 101 degrees Fahrenheit, chills, full body ache/pain/dizziness. 1/26/2022 - less pain but still with full body ache/pain, dizziness, slight increase in temperature close to 100 degrees Fahrenheit; lethargy. 1/27/2022 - slight fever, lethargy, dizziness, left-side, upper extremity severe pain, fatigue. 1/28/2022 - left-side, upper extremity, lethargy, dizziness, fatigue, cough, congestion. 1/29/2022 - cough, congestion, frequent sneezing.
Pt vaccinated with DTP/OPV mother reports high fever of about 103. Also, cried as if in pain off & on for 4 hrs straight.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. There was no information about patients' concomitant medications and pertinent medical history reported. On an unknown dates, multiple unspecified patients were vaccinated with improperly stored doses of VARIVAX lot # L017142, expiry date 13-MAY-2017 (routes and sites of administration, dose were not reported). No adverse effects were reported. Follow-up information was received on 07-DEC-2015, that all telephone attempts to obtain follow-up information have been unsuccessful. Follow-up information has been received on 08-DEC-2015 from the reporting nurse. She reported that she would have to research the request made for patient identifiers, lot number and expiration date and dates of vaccination. Follow up information has been received from the nurse on 14-DEC-2015. This case concerns a 16 year old patient. On 15-SEP-2015, the patient was vaccinated with VARIVAX. This is one of several reports received from the same reporter. Additional information has been requested.